Haoxi Health FY2026: Revenue Up 67% But $9.5M Loss, Material Weaknesses, and Massive Authorized Share Increase
HAO is trading near its 52-week low of $2.61 (4.6% above the low) on light trading volume (0.1× avg).
Summary
Haoxi Health swung to a $9.5M FY2026 loss despite 67% revenue growth, disclosed material ICFR weaknesses and an auditor change, and authorized up to 5 trillion Class A shares — massive dilution headroom for a company trading near its 52-week low.
Key Events · Earnings and Guidance · HAO
-
FY2026 Net Loss of $9.54M
Revenue grew 67% to $54.83M, but the company swung from $3.88M net income in FY2025 to a $9.54M net loss in FY2026, driven by a $6.07M credit loss allowance and $1.5M intangible asset impairment.
-
Material Weaknesses in ICFR
Management disclosed material weaknesses in internal controls over financial reporting, including lack of U.S. GAAP expertise and inadequate review controls, and concluded ICFR was not effective as of June 30, 2026.
-
Auditor Change
The company dismissed Wei, Wei & Co. LLP and appointed HCL, PLLC as its independent auditor effective April 3, 2026, with no disagreements or reportable events disclosed.
-
Massive Authorized Share Increase
Authorized share capital was increased to 5,000,000,000,000 Class A shares and 500,000,000,000 Class B shares, creating enormous potential dilution headroom relative to the 111,127 shares outstanding.
Analysis · HAO · Trade & Services
Haoxi Health's FY2026 annual report reveals a dramatic swing from $3.88M net income to a $9.54M net loss despite 67% revenue growth to $54.83M. The loss was driven by a $6.07M allowance for credit losses on third-party loans and prepaid advertising, a $1.5M impairment of digital assets, and a $6.02M increase in G&A expenses. The company also disclosed material weaknesses in internal controls, an auditor change, and a massive expansion of authorized share capital to 5 trillion Class A shares — creating enormous potential dilution headroom. The stock trades near its 52-week low at $2.73, and the company has executed multiple reverse splits (1:128 and 1:20) to maintain Nasdaq listing compliance.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 34.9% of the 1009 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HAO was trading at $2.73 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $1.7M. The 52-week trading range was $2.61 to $4,352.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.